SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

SomaLogic, Inc. SLGCW NASDAQ

NASDAQ Global Market • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

SomaLogic, Inc. (SLGCW) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.09. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $98M, +46.4%/yr average growth. Net income is $109M (loss), growing at -24.2%/yr. Net profit margin is -111.8% (negative). Gross margin is 55.6% (+110.1 pp trend).

Balance sheet: total debt is $2M against $563M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 13.42 (strong liquidity). Debt-to-assets is 0.4%. Total assets: $647M.

Analyst outlook: 4 / 6 analysts rate SLGCW as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future 55/100 (Partial), Income 10/100 (Fail).

SLGCW SharesGrow Score Overview

55/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 58/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 50/100

Gross margin is + market cap

FUTURE 55/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SLGCW

No analyst coverage available for this stock.

SLGCW: +46.4%/yr revenue is, -24.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet SLGCW: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 13.42 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SLGCW: Gross margin is 55.6% (+110.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.

View details →

Analyst outlook: 4 / 6 analysts rate SLGCW as buy (67%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SLGCW: Net profit margin is -111.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.086-0.1148

Volume33.64K

Avg Volume (30D)33.64K

Market Cap$396.23M

Beta (1Y)1.64

Share Statistics

EPS (TTM)-0.59

Shares Outstanding$183.99M

IPO Date2021-09-02

Employees451

CEOStephen A. Williams BS, MB,

Financial Highlights & Ratios

Revenue (TTM)$97.67M

Gross Profit$54.3M

EBITDA$-175.76M

Net Income$-109.16M

Operating Income$-175.76M

Total Cash$539.59M

Total Debt$2.48M

Net Debt$-419.35M

Total Assets$647.37M

Price / Earnings (P/E)-0.1

Price / Sales (P/S)4.06

Analyst Forecast

Rating ConsensusBuy

Analysts Covering6

Buy 67% Hold 33% Sell 0%

Company Info

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS83444K1135

Price Chart

SLGCW

SomaLogic, Inc. ↗ · NASDAQ Global Market

Healthcare • Medical - Healthcare Information Services

0.09 52WK RANGE 0.11

People Also View

Roivant Sciences Ltd.

SomaLogic, Inc.

Sharecare, Inc.

Quantum-Si incorporated

eFFECTOR Therapeutics, Inc.

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message